San Francisco certainly isn’t the only major U.S. city experiencing high office vacancy rates, but its numbers are among the most severe.
We took a look at Cushman & Wakefield’s Office MarketBeat reports to see how the city’s office vacancy rates and asking rent compare to other cities. When putting them side by side with 10 other metros, a few things stand out. San Francisco’s vacancy rate has the largest percent increase between the fourth quarter of 2019 and the end of 2022, thanks in part to how tight the market was before the pandemic.
เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
Largest San Francisco Office Leases - San Francisco Business TimesThis List includes San Francisco office leases signed in 2022. Information was obtained from CBRE, Cushman & Wakefield, JLL, Kidder Matthews, Colliers, and SFBT research.
แหล่ง: SFBusinessTimes - 🏆 78. / 68 อ่านเพิ่มเติม »
Mass layoffs will result in surge in business startups, new opportunities - San Francisco Business TimesThe mass layoffs spreading across the economy will result in a surge of new business startups, but this time the opportunities are different and plentiful.
แหล่ง: SFBusinessTimes - 🏆 78. / 68 อ่านเพิ่มเติม »
How commuting factors into the work-from-home debate - San Francisco Business TimesThere are hidden costs when requiring employees to come back to the office — and it's not just potentially missing out on talent
แหล่ง: SFBusinessTimes - 🏆 78. / 68 อ่านเพิ่มเติม »
Lam Research announces layoffs at earnings - San Francisco Business TimesThe Fremont-based tool business said that the layoffs represent roughly 7% of its global employees and will affect a wide swath of the staff.
แหล่ง: SFBusinessTimes - 🏆 78. / 68 อ่านเพิ่มเติม »
Retiring Vir CEO George Scangos on building great companies - San Francisco Business TimesHe built companies across cancer, spinal muscular atrophy and an accelerate treatment for Covid-19 and, potentially, other major infectious diseases at three multibillion-dollar drug developers. Now he's handing Vir's reins to outgoing Bayer exec Marianne De Backer.
แหล่ง: SFBusinessTimes - 🏆 78. / 68 อ่านเพิ่มเติม »